BAKER BIOTECH CAPITAL GP LLC 4
4 · SEATTLE GENETICS INC /WA · Filed Aug 12, 2004
Insider Transaction Report
Form 4
Baker Biotech Capital (GP), LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2004-08-10$5.32/sh+1,061$5,642→ 60,458 total(indirect: See Footnote) - Purchase
Common Stock
2004-08-12$5.58/sh+26,535$148,020→ 92,120 total(indirect: See Footnote) - Purchase
Common Stock
2004-08-11$5.42/sh+4,242$22,988→ 65,585 total(indirect: See Footnote) - Purchase
Common Stock
2004-08-11$5.49/sh+885$4,859→ 61,343 total(indirect: See Footnote)
Footnotes (2)
- [F1]In addition to Baker Biotech Capital (GP), LLC, this Form 4 is being filed jointly by Julian C. Baker and Felix J. Baker, each of whom has the same business address as Baker Biotech Capital (GP), LLC and may be deemed to have a pecuniary interest in securities owned by it. Because of certain business relationships with other shareholders of the Issuer, the Reporting Persons have filed on Schedule 13D as if they were a member of a group with such shareholders. However, the Reporting Persons disclaim that they and any other person or persons, including those persons with whom the Reporting Persons have filed a Schedule 13D, in fact constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5 thereunder, or that they are the beneficial owners of any securities owned by any other person. Felix J. Baker is a director of the Issuer.
- [F2]Represents shares of common stock owned directly by Baker Biotech Fund I, L.P., the sole general partner of which is Baker Biotech Capital, L.P., a limited partnership of which the sole general partner is Baker Biotech Capital (GP), LLC. Felix J. Baker and Julian C. Baker are the controlling members of Baker Biotech Capital (GP), LLC.